Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma

Glioblastoma (GBM) is the highly malignant glioma and exhibits microvascular proliferation. PCR mRNA arrays and immunohistochemical stains on tissue microarray demonstrated that the expression level of PDGFRB in GBM microvascular proliferation was significantly higher than that in GBM tumor cells while the expression level of EGFR was lower in microvascular proliferation than in GBM tumor cells. PDGFRB protein was selectively expressed in pericytes in GBM microvascular proliferation. By analyzing The Cancer Genome Atlas (TCGA) datasets for GBM, it was found that genomic DNA alterations were the main reason for the high expression of EGFR in GBM tumor cells. Our miRNA microarray data showed that microRNAs (miRNAs) (miR-193b-3p, miR-518b, miR-520f-3p, and miR-506-5p) targeting PDGFRB were downregulated in microvascular proliferation, which might be the most likely reason for the high expression of PDGFRB in GBM microvascular proliferation. The increase of several miRNAs (miR-133b, miR-30b-3p, miR-145-5p, and miR-146a-5p) targeting EGFR in GBM microvascular proliferation was one of the reasons for the lack of expression of EGFR in GBM microvascular proliferation. These findings implicated that miRNAs, such as miR-506, miR-133b, miR-145, and miR-146a, that target PDGFRB or EGFR, might be potential therapeutic agents for GBM. A new generation of targeted therapeutic agents against both EGFR and PDGFRB might be developed in the future.

[1]  B. Bao,et al.  Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling. , 2014, Cancer letters.

[2]  P. Wen,et al.  Bevacizumab for recurrent malignant gliomas , 2008, Neurology.

[3]  Hsien-Da Huang,et al.  miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions , 2013, Nucleic Acids Res..

[4]  A. Órfão,et al.  Molecular and Genomic Alterations in Glioblastoma Multiforme. , 2015, The American journal of pathology.

[5]  S. Leung,et al.  Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. , 1998, The American journal of surgical pathology.

[6]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[7]  J. Tonn,et al.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade , 2007, Journal of Neuro-Oncology.

[8]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[9]  Changwei Lin,et al.  Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR. , 2015, Molecular medicine reports.

[10]  W. Park,et al.  miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines , 2013, PloS one.

[11]  M. Lindström,et al.  PDGF and PDGF receptors in glioma , 2012, Upsala journal of medical sciences.

[12]  M. J. van den Bent,et al.  Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Chopp,et al.  MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells , 2012, Oncology reports.

[14]  M. Mrugala,et al.  Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. , 2009, Neurology.

[15]  Dan Li,et al.  MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[16]  T. Mikkelsen,et al.  MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor , 2013, PloS one.

[17]  David J. Yang,et al.  The natural history of EGFR and EGFRvIII in glioblastoma patients , 2005, Journal of Translational Medicine.

[18]  Wei Zhang,et al.  MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer , 2015, The Journal of pathology.

[19]  MiR-133b Contributes to Arsenic-Induced Apoptosis in U251 Glioma Cells by Targeting the hERG Channel , 2015, Journal of Molecular Neuroscience.

[20]  Guiyan Xu,et al.  ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation , 2016, Journal of Neuro-Oncology.

[21]  Lihua Zhang,et al.  MiR‐146a suppresses tumor growth and progression by targeting EGFR pathway and in a p‐ERK‐dependent manner in castration‐resistant prostate cancer , 2012, The Prostate.

[22]  W. Cho,et al.  MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1 , 2011, RNA biology.

[23]  A. Shiras,et al.  MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. , 2013, Neuro-oncology.

[24]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[25]  Tongli Wang,et al.  miR‐193b promotes cell proliferation by targeting Smad3 in human glioma , 2014, Journal of neuroscience research.

[26]  Yu-guang Liu,et al.  MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1 , 2014, Tumor Biology.

[27]  Junhua Zheng,et al.  Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1 , 2015, PloS one.

[28]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[29]  Ying Wang,et al.  miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer. , 2015, The American journal of pathology.

[30]  Junhua Zheng,et al.  MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1 , 2015, PloS one.

[31]  Jun Guo,et al.  miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2 , 2014, NeuroMolecular Medicine.

[32]  Yue Wang,et al.  MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3′UTR , 2014, Acta Pharmacologica Sinica.

[33]  F. Ahmed.  Role of miRNA in carcinogenesis and biomarker selection: a methodological view , 2007, Expert review of molecular diagnostics.

[34]  Ilya Shmulevich,et al.  MiR‐506 suppresses proliferation and induces senescence by directly targeting the CDK4/6–FOXM1 axis in ovarian cancer , 2014, The Journal of pathology.